Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joseph A. Walder is active.

Publication


Featured researches published by Joseph A. Walder.


Molecular therapy. Nucleic acids | 2013

Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier

Kim A. Lennox; Richard Owczarzy; Derek M. Thomas; Joseph A. Walder; Mark A. Behlke

Anti-microRNA oligonucleotides (AMOs) are steric blocking antisense reagents that inhibit microRNA (miRNA) function by hybridizing and repressing the activity of a mature miRNA. First generation AMOs employed 2′-O-Methyl RNA nucleotides (2′OMe) with phosphorothioate (PS) internucleotide linkages positioned at both ends to block exonuclease attack. Second generation AMOs improved potency through the use of chemical modifications that increase binding affinity to the target, such as locked nucleic acid (LNA) residues. However, this strategy can reduce specificity as high binding affinity compounds can bind to and suppress function of related sequences even if one or more mismatches are present. Further, unnatural modified nucleic acid residues can have toxic side effects. In the present study, a variety of non-nucleotide modifiers were screened for utility in steric blocking antisense applications. A novel compound, N,N-diethyl-4-(4-nitronaphthalen-1-ylazo)-phenylamine (“ZEN”), was discovered that increased binding affinity and blocked exonuclease degradation when placed at or near each end of a single-stranded oligonucleotide. This new modification was combined with the 2′OMe RNA backbone to make ZEN-AMOs. The new ZEN-AMOs have high potency and can effectively inhibit miRNA function in vitro at low nanomolar concentrations, show high specificity, and have low toxicity in cell culture.


BMC Biotechnology | 2011

RNase H-dependent PCR (rhPCR): improved specificity and single nucleotide polymorphism detection using blocked cleavable primers

Joseph Dobosy; Scott Rose; Kristin Beltz; Susan Rupp; Kristy M Powers; Mark A. Behlke; Joseph A. Walder

BackgroundThe polymerase chain reaction (PCR) is commonly used to detect the presence of nucleic acid sequences both in research and diagnostic settings. While high specificity is often achieved, biological requirements sometimes necessitate that primers are placed in suboptimal locations which lead to problems with the formation of primer dimers and/or misamplification of homologous sequences.ResultsPyrococcus abyssi (P.a.) RNase H2 was used to enable PCR to be performed using blocked primers containing a single ribonucleotide residue which are activated via cleavage by the enzyme (rhPCR). Cleavage occurs 5-to the RNA base following primer hybridization to the target DNA. The requirement of the primer to first hybridize with the target sequence to gain activity eliminates the formation of primer-dimers and greatly reduces misamplification of closely related sequences. Mismatches near the scissile linkage decrease the efficiency of cleavage by RNase H2, further increasing the specificity of the assay. When applied to the detection of single nucleotide polymorphisms (SNPs), rhPCR was found to be far more sensitive than standard allele-specific PCR. In general, the best discrimination occurs when the mismatch is placed at the RNA:DNA base pair.ConclusionrhPCR eliminates the formation of primer dimers and markedly improves the specificity of PCR with respect to off-target amplification. These advantages of the assay should find utility in challenging qPCR applications such as genotyping, high level multiplex assays and rare allele detection.


Nucleic Acids Research | 1990

Targeted degradation of mRNA in Xenopus oocytes and embryos directed by modified oligonucleotides: studies of An2 and cyclin in embryogenesis

John M. Dagle; Joseph A. Walder; Daniel L. Weeks


Antisense research and development | 1991

Pathways of Degradation and Mechanism of Action of Antisense Oligonucleotides in Xenopus laevis Embryos

John M. Dagle; Daniel L. Weeks; Joseph A. Walder


Nucleic Acids Research | 1991

Physical properties of oligonucleotides containing phosphoramidate-modified internucleoside linkages

John M. Dagle; Mark E. Andracki; Rene J. DeVine; Joseph A. Walder


Archive | 2009

RNase H-based assays utilizing modified RNA monomers

Joseph A. Walder; Mark A. Behlke; Scott Rose; Josesph Dobosy


Nucleic Acids Research | 1993

Use of PCR primers containing a 3'-terminal ribose residue to prevent cross-contamination of amplified sequences

Roxanne Y. Walder; Janel R. Hayes; Joseph A. Walder


Archive | 2008

Fluorescence quenching azo dyes, their methods of preparation and use

Andrei Laikhter; Mark A. Behlke; Joseph A. Walder; Kevin William Roberts; Yawfui Yong


Archive | 2009

Compounds and methods for labeling oligonucleotides

Andrei Laikhter; Joseph A. Walder; Mark A. Behlke; Mikhail Podyminogin; Yawfui Yong


Archive | 1994

DNA molecules stabilized by modifications of the 3′-terminal phosphodiester linkage

Joseph A. Walder; Roxanne Y. Walder; Paul S. Eder; John M. Dagle

Collaboration


Dive into the Joseph A. Walder's collaboration.

Top Co-Authors

Avatar

Mark A. Behlke

Integrated DNA Technologies

View shared research outputs
Top Co-Authors

Avatar

Richard Owczarzy

Integrated DNA Technologies

View shared research outputs
Top Co-Authors

Avatar

Scott Rose

Integrated DNA Technologies

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joseph Dobosy

Integrated DNA Technologies

View shared research outputs
Top Co-Authors

Avatar

Andrei Laikhter

Integrated DNA Technologies

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jeffrey A. Manthey

Integrated DNA Technologies

View shared research outputs
Top Co-Authors

Avatar

Roxanne Y. Walder

Integrated DNA Technologies

View shared research outputs
Researchain Logo
Decentralizing Knowledge